ESMO Virtual Congress 2020

Welcome to our ESMO Virtual Congress landing page. Here you can find out more about our Elsevier's Oncology Journal Network, and browse our Advances in Medical Oncology, Immuno-Oncology Technology and COVID-19 article collections.

ESMO’s Journal Portfolio

While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology and Immuno-Oncology Technology and we are delighted to announce that from January 2021 we will partner with ESMO to publish ESMO Open.

ESMO Caner Horizones New

From January 2021

Advances in Medical Oncology Article Collection

Innovation in cancer research and clinical oncology is leading to tangible progress in the treatment and management of patients. In this curated Collection, we highlight the latest developments in therapeutic approaches, prognostic factors, and trials across multiple tumor types that are contributing to a better understanding of cancer and to improved clinical outcomes:

This collection was curated by:

Ana Batista, PhD

Ana Batista is the Lead Editor of Elsevier Oncology Journals


Elsevier's Oncology Journal Network

We’ll help you find the right home for your research – fast

Publishing your work can be time-consuming, especially if the first journal you submit to isn’t right for your research. With over 40 journals, including Annals of Oncology, The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right home for your research.

 

Immuno-Oncology Technology articles

Immuno-Oncology Technology (IOTECH) is a new, peer-reviewed open access journal from ESMO publishing high quality original research articles, reviews and editorials focusing on novel immuno-oncology topics and developments, both clinically and preclinically.

IOTECH banner


ClinicalPath

The oncology treatment arena is becoming increasingly complex, and time pressures are compounded by the backlog of cases caused by the COVID-19 global pandemic.

See how ClinicalPath can help users gain fast and easy access to the right treatment options during challenging times.

ClinicalPath Banner


COVID-19 Oncology collection

COVID-19 Banner